Analgesic effect of esketamine on patients undergoing thoracoscopic pulmonary lobectomy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200056524

Enrollment

Unknown

Registered

2022-02-07

Start date

2022-02-17

Completion date

Unknown

Last updated

2024-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute post-operative pain

Interventions

Experimental group:Esketamine

Control group:Normal saline

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing thoracoscopic lobectomy at selected time; 2. ASA classification: I-III; 3. Aged 18-75 years.

Exclusion criteria

Exclusion criteria: 1. Patients with drug allergy; 2. Patients with neuropsychiatric history; 3. Patients who refuse to cooperate; 4. Serious surgical complications occurred during perioperative period.

Design outcomes

Primary

Measure	Time frame
Visual analogue scale of pain;White blood cell count;	—

Secondary

Measure	Time frame
Adverse effect after surgery;Time of chest tube extubation;	—

Countries

China

Contacts

Public ContactWang Zhongyun

The First Affiliated Hospital of Nanjing Medical University

zywang1970@126.com+86 13913916609

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026